Recombinant Anti-PTPRC × Anti-CD79B Bispecific Antibody (Tandem Diabody) (CAT#: TAND-LC023)
The anti-CD45/CD79 antibody specifically binds to CD45 and CD79. By inhibiting the function of B cell, the bispecific antibody can be potentially used in the treatment of autoimmune disease.
Specific Inquiry
Specifications
- Target
- CD45 & CD79
- Type
- Tandem Diabody
- Species Reactivity
- Human
- Target 1
- CD45
- Host Species 1
- Rabbit
- Target 2
- CD79b
- Host Species 2
- Rabbit
- Application
- FuncS, Promising therapeutic agent
- Related Disease
- Autoimmune disease
Target
- Target 1
- CD45
- Gene ID
- 5788
- UniProt ID
- M9MML4
- Alternative Names
- PTPRC; protein tyrosine phosphatase, receptor type, C; LCA; LY5; B220; CD45; L-CA; T200; CD45R; GP180; receptor-type tyrosine-protein phosphatase C; CD45 antigen; T200 glycoprotein; T200 leukocyte common antigen; protein tyrosine phosphatase, receptor type, c polypeptide
- Target 2
- CD79b
- Gene ID
- 974
- UniProt ID
- P40259
- Alternative Names
- CD79B; CD79b molecule, immunoglobulin-associated beta; B29; IGB; AGM6; B-cell antigen receptor complex-associated protein beta chain; Ig-beta; B-cell-specific glycoprotein B29; immunoglobulin-associated B29 protein; CD79b antigen (immunoglobulin-associated beta);
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAND-LC023. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.